Developing a novel reference region for [18F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies
European Journal of Nuclear Medicine and Molecular Imaging · 2025-11 · 52 (13) · 5098-5112
DOI: 10.1007/s00259-025-07396-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 10.06.2025. Verfasst von Lukas Frontzkowski und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Feodor-Lynen-Straße 17, Munich, 81377, Germany. lukas.frontzkowski…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Tauopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Klinikum der Universität München.
Abstract (Originalsprache)
Purpose
Progressive supranuclear palsy (PSP) is a fatal 4-repeat (4R) tauopathy with progressive movement phenotypes. In-vivo 4R tau biomarkers are therefore crucial for PSP diagnosis, monitoring, and treatment evaluation. The tau-PET tracer [ 18 F]PI-2620 binds to 4R tau and shows increased uptake in PSP-associated regions (e.g., globus pallidus), and is therefore a candidate 4R tau biomarker. However, commonly used cerebellar tau-PET reference regions show regional proximity to cerebellar 4R tau deposits in PSP, confounding semiquantitative [ 18 F]PI-2620 assessments. Therefore, we employed bias-free image-derived input function (IDIF) PET quantification to identify an optimized data-driven reference region for assessing 4R tau in PSP.
Methods
Dynamic [ 18 F]PI-2620 PET (60 min) was acquired in 58 PSP-Richardson Syndrome (PSP-RS) and 18 healthy controls (HC). IDIF-modelling with carotid timeseries derived total distribution volume (VT). Iteratively normalizing VT images to atlas-based white matter (WM), we identified reference candidates maximizing PSP-RS vs. HC pallidum differences. The best-performing WM references were combined to a temporo-orbital WM reference, validated in PSP-nonRS ( n = 54), HC ( n = 18), and disease controls (α-synucleinopathies, n = 21; Alzheimer’s disease (AD, n = 22) using VT-ratios (VTr) and 20-40min static standardized uptake value ratios (SUVr).
Results
Using the data-driven temporo-orbital WM reference, PSP patients showed significantly higher basal ganglia [ 18 F]PI-2620 signal vs. HC compared to cerebellar normalization. Receiver operating curve (ROC) analysis confirmed higher diagnostic accuracy using the temporo-orbital WM reference. Pallidum [ 18 F]PI-2620 showed significant associations with clinical disease severity exclusively when using the novel temporo-orbital WM reference.
Conclusions
A data-driven temporo-orbital WM reference optimizes [ 18 F]PI-2620 PET assessment for PSP diagnosis, outperforming conventional cerebellar references used in tau-PET imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Feodor-Lynen-Straße 17, Munich, 81377, Germany. lukas.frontzkowski@med.uni-muenchen.de.
- Department of Nuclear Medicine, LMU University Hospital, Marchioninistraße 15, Munich, 81377, Germany. lukas.frontzkowski@med.uni-muenchen.de.
- Department of Nuclear Medicine, LMU University Hospital, Marchioninistraße 15, Munich, 81377, Germany.
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Feodor-Lynen-Straße 17, Munich, 81377, Germany.
- Department of Neurology, LMU University Hospital, Munich, Germany.
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
ORCID-Profile: Lukas Frontzkowski
Förderung
- Klinikum der Universität München
Zitieren
APA
Frontzkowski, L., Gnörich, J., Gross, M., Dehsarvi, A., Roemer-Cassiano, S. N., Palleis, C., Katzdobler, S., Dewenter, A., Steward, A., Biel, D., Hirsch, F., Zhu, Z., Levin, J., Stephens, A. W., Müller, A., Koglin, N., Bischof, G. N., Kovacs, G. G., Höglinger, G. U., …, & Franzmeier, N. (2025). Developing a novel reference region for [18F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies. European Journal of Nuclear Medicine and Molecular Imaging, 52(13), 5098-5112. https://doi.org/10.1007/s00259-025-07396-8
Vancouver
Frontzkowski L, Gnörich J, Gross M, Dehsarvi A, Roemer-Cassiano SN, Palleis C, et al. Developing a novel reference region for [18F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(13):5098-5112. doi:10.1007/s00259-025-07396-8
BibTeX
@article{Frontzkowski2025,
author = {Frontzkowski, Lukas and Gnörich, Johannes and Gross, Mattes and Dehsarvi, Amir and Roemer-Cassiano, Sebastian N and Palleis, Carla and Katzdobler, Sabrina and Dewenter, Anna and Steward, Anna and Biel, Davina and Hirsch, Fabian and Zhu, Zeyu and Levin, Johannes and Stephens, Andrew W and Müller, Andre and Koglin, Norman and Bischof, Gérard N and Kovacs, Gabor G and Höglinger, Günter U and Brendel, Matthias and Franzmeier, Nicolai},
title = {Developing a novel reference region for [18F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
volume = {52},
number = {13},
pages = {5098--5112},
doi = {10.1007/s00259-025-07396-8}
}
EUVIMED